The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20141448: Carl C. Icahn; Hertz Global Holdings, Inc.
20141450: Post Holdings, Inc.; ABC Peanut Butter, LLC
20141470: Kainos Capital Partners, LP; Blue Point Capital Partners II, L.P.
20141473: Special Purchase Company, a to-be-formed Korean corporation; Hyundai Logistics Co., Ltd.
20141474: MedAssets, Inc.; Michael A. Sachs
20141475: Ultra Petroleum Corp.; Royal Dutch Shell plc
20141478: Mercury New Holdco Inc.; Sinclair Broadcast Group, Inc.
20141479: Buckeye Partners, L.P.; Claude Dauphin
20141481: Connexus Credit Union; Endura Financial Federal Credit Union
20141486: Khosla Ventures, II, LP; AliphCom
20141489: John C. Malone; Liberty Global plc
20141491: W.A. Baxters & Sons (Holdings) Limited; DDJ Capital Management, LLC
20141497: dievini Hopp BioTech holding GmbH & Co. KG; LTS Lohmann Therapie-Systeme AG
Chairwoman Edith Ramirez Media Statement on FTC Suing Pharmaceutical Companies for Illegally Blocking Consumer Access to Lower-Cost Versions of AndroGel
Actavis PLC and Forest Laboratories, In the Matter of
Pharmaceutical companies Actavis plc and Forest Laboratories, Inc. agreed to sell or relinquish their rights to four generic pharmaceuticals that treat hypertension, angina, cirrhosis, and prevent seizures to settle FTC charges that Actavis’s acquisition of Forest likely would be anticompetitive. According to the FTC’s complaint, Actavis’s acquisition of Forest, as originally proposed, would violate federal antitrust laws by reducing competition in the markets for three current generic products. In addition, the FTC’s complaint also alleges that the proposed transaction would delay the introduction of another generic drug. Under the proposed FTC settlement order, the companies have agreed to relinquish their rights to market generic diltiazem hydrochloride (AB4) to Valeant Pharmaceuticals International, Inc.; sell generic ursodiol and generic lamotrigine ODT to Impax Laboratories, Inc.; and sell generic propranolol hydrochloride to Catalent Pharma Solutions, Inc. Under the terms of the proposed settlement, Actavis and Forest must ensure the viability, marketability, and competitiveness of the drugs that are
being divested until they are sold.
Hertz Global Holdings, Inc., In the Matter of
Hertz Global Holdings, Inc. agreed to sell its Advantage Rent A Car business, as well as the rights to operate 29 Dollar Thrifty on-airport locations around the country, to settle charges that Hertz’s $2.3 billion acquisition of Dollar Thrifty would have been harmed competition in 72 airport markets throughout the United States.